CD68 and Bloom syndrome: Both RSV and RSV-LNCs pretreatment counteracted macrophage infiltration leading to a significant decrement in the CD68+ cell number and immunoreactivity versus the BLM group (p < .001 for all), although levels in RSV group were significantly higher than that of the control and RSV-LNCs groups (all p < .001) (Figure 6A1–A5, 6C, and 6D).